CEO, AllazoHealth
Clifford is the CEO of AllazoHealth, a company that uses predictive analytics to better solve the problem of medication non-adherence. AllazoHealth’s award winning and patent pending AllazoEngine® platform forecasts individual patients’ adherence to each of their medications, anticipates how medication adherence interventions will influence those patients, and targets the right interventions to the right patients at the right time. Allazo provides its services both as a stand-alone analytics solution and as a full-service medication adherence solution including intervention delivery. Allazo’s solutions cover Stars/HEDIS/QRS/DSRIP/Medicaid metrics as well as programs to reduce medical spend and improve outcomes. Its client base oversees the health of nearly 30 million patients.
Previously Clifford developed CVS Caremark’s award-winning “Pharmacy Advisor” medication adherence program. Earlier in his career, Cliff developed analytics solutions for Boston Consulting Group's health care practice. He graduated from the University of Pennsylvania’s dual-degree Management and Technology program where he studied management, engineering and mathematics. He also studied at Wharton in the Health Care Management MBA program.